KYNTRA BIO, INC. (KYNB) Insider Trading

KYNTRA BIO, INC. (KYNB) has 2 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 9, 2026.

Filings
2
Purchases
0
$0
Sales
0
$0
Insiders
2

Most active KYNB insiders

Wettig Thane
CEO
0 bought · 0 sold · Sept. 9, 2026
$2K
DeLucia David
Chief Financial Officer
0 bought · 0 sold · Sept. 9, 2026
$188

Latest KYNB Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Sept. 9, 2026 filed Sept. 6, 2026 DeLucia David Chief Financial Officer $188 22 −1% No
Sept. 9, 2026 filed Sept. 6, 2026 Wettig Thane CEO $1,787 209 −1% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when KYNB insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free